C000157182 Performance — ProShares UltraPro Short Nasdaq Biotechnology

Data updated: 2020-04-28

In the 12 months to Feb 2020 the fund took in a net $936K, and assets reached $3.63M.

C000157182 Growth of $100

What $100 invested in ProShares UltraPro Short Nasdaq Biotechnology grew to, compounded from monthly returns reported on SEC Form N-PORT, against the Trading - Leveraged category average over the same months.

PeriodC000157182Category average
Since data start (Sep 2019 – Feb 2020)$67$101

C000157182 Annual Returns

Calendar-year total returns of ProShares UltraPro Short Nasdaq Biotechnology, compounded from monthly SEC N-PORT returns. Partial years show the months covered.

YearTotal return
2020 (Jan–Feb)+13.29%
2019 (Sep–Dec)−40.44%

C000157182 Monthly Returns

Monthly total returns as reported on SEC Form N-PORT.

YearJanFebMarAprMayJunJulAugSepOctNovDec
2020+17.7%−3.7%——————————
2019————————+9.3%−21.0%−28.8%−3.2%

C000157182 Risk

Risk measures from monthly returns over Sep 2019 – Feb 2020.

  • Best month: +17.70% (Jan 2020)
  • Worst month: −28.77% (Nov 2019)

C000157182 Fund Flows

Monthly money in and out of ProShares UltraPro Short Nasdaq Biotechnology, from SEC Form N-PORT.

  • 12-month net flow: $936K
  • 12-month gross sales (incl. reinvestments): $936K
MonthSalesRedemptionsNet flow
Feb 2020$0$0$0
Jan 2020$0$0$0
Dec 2019$936K$0$936K
Nov 2019$0$0$0
Oct 2019$0$0$0
Sep 2019$0$0$0

C000157182 Assets Under Management

Net assets of ProShares UltraPro Short Nasdaq Biotechnology by report date, from SEC N-PORT filings.

Report dateNet assets
2020-02-29$3.63M
2019-11-30$2.37M

For information only. Not investment advice: figures are as reported in SEC filings and may contain errors or be out of date. Past performance does not guarantee future results.